Pick up a bottle of bestselling Japanese skincare—such as Curél facial milk, Sekkisei lotion, or Melano CC essence—and you will often spot the English word "Medicated" stamped on the box, alongside Japanese characters for yakuyou or iyakubugaihin. For international shoppers unfamiliar with Japanese cosmetic law, this label frequently sparks concern. Does "medicated" mean the bottle contains prescription drugs, antibiotics, or topical steroids? Is it too harsh for everyday use?

In Japanese skincare, the reality is reassuringly different. Rather than indicating an aggressive pharmaceutical drug, the label signifies that the product belongs to a unique, highly regulated regulatory tier known as a quasi-drug.

Understanding how Japanese quasi-drugs are formulated, tested, and classified reveals why they are among the most reliable, barrier-friendly products in the world of J-Beauty.

Collection of Japanese skincare bottles arranged on a clean white pedestal

Quick answer: In Japan, a quasi-drug (iyakubugaihin, often labeled on packaging as yakuyou or "Medicated") is an official regulatory category positioned midway between general cosmetics and pharmaceutical medicines. It refers to skincare formulated with government-approved active ingredients at strictly verified, safe concentrations to provide mild preventative care—such as preventing blemishes, calming skin roughness, or reducing sun-induced dark spots. Japanese quasi-drugs are designed for gentle, long-term daily use, not short-term medical crisis intervention.

What Is a Japanese Quasi-Drug (Iyakubugaihin)?

To understand why Japanese skincare features this unique category, consider how beauty products are regulated globally. In most Western markets, a product is either classified as a cosmetic (which cleanses, moisturizes, and beautifies without making active physiological claims) or an over-the-counter drug (such as high-strength acne washes or sunscreens governed by pharmaceutical rules).

Conclusion: Japan's legal framework features a dedicated intermediate category (*iyakubugaihin*) bridging everyday cosmetics and prescription drugs, ensuring verified active efficacy with cosmetic-level daily safety.

Japan's Pharmaceuticals and Medical Devices Act (PMD Act), overseen by the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA), recognizes a distinct three-tier classification:

  1. Pharmaceutical Drugs (Iyakuhin): Formulated to address specific diagnosed medical conditions. They carry potent biological activity, require strict medical oversight, and cannot be used casually as daily cosmetic care.
  2. Quasi-Drugs (Iyakubugaihin): Skincare products formulated with approved active ingredients to deliver mild, preventative benefits—such as preventing roughness, moderating excess sebum, or inhibiting melanin synthesis. They undergo rigorous pre-market government review but are safe for unassisted daily application. Under PMDA guidelines:

    "products contain active ingredients are generally classified as quasi-drugs in Japan"[1]

  3. General Cosmetics (Keshouhin): Everyday beauty formulations—such as hydrating toners, gentle face creams, and makeup—intended to clean, moisturize, and beautify the skin without active preventative medicinal claims.

When a brand registers a quasi-drug for consumer retail in Japan, it commonly uses the term yakuyou (literally "medicinal use") on the front of the packaging, which global exporters translate as "Medicated."

Cosmetics vs Quasi-Drugs vs Western Cosmeceuticals

In Western beauty marketing, brands often use the informal buzzword "cosmeceutical" to describe active-heavy serums. However, in Western law, "cosmeceutical" has no official legal definition. In Japan, by contrast, quasi-drugs are formal legal entities with strict safety boundaries.

Conclusion: While Western "cosmeceuticals" are unregulated marketing labels, Japanese quasi-drugs must receive formal government approval for each active ingredient, dosage, and preventative claim.

The table below outlines the core differences among these categories:

Scroll horizontally to view full table

Feature Japanese General Cosmetics Japanese Quasi-Drugs (Yakuyou) Western "Cosmeceuticals"
Legal Status Strictly defined under PMD Act Formal government-regulated tier Unofficial marketing term; legally cosmetics
Active Ingredients General conditioning ingredients Government-approved active ingredients at set doses Brand-determined active levels without set ceilings
Efficacy Claims Limited to moisturizing, cleansing, beautifying Legally permitted specific preventative claims Unregulated marketing claims (e.g., "clinical strength")
Ingredient Order Full descending concentration order (INCI standard) "Active Ingredient" first, followed by "Other Ingredients" Full descending concentration order
Primary Function Daily hydration, barrier softening, cleansing Preventing roughness, spots, blemishes, or irritation Aggressive cellular turnover or rapid correction
Daily Safety Exceptionally gentle Clinically balanced for long-term daily tolerance Variable; can trigger irritation or barrier peeling